1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

Introduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition, tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic receptor 7 (GRM7) and N-acetyltransferase 2 (NAT2) are some of the genetic markers for presbycusis. Objectives: To explore patterns of hearing loss and the role of GRM7 and NAT2 as possible markers of presbycusis and tinnitus in a Portuguese population sample. Materials and Methods: Tonal and speech audiometry, tinnitus assessment, clinical interview, and DNA samples were obtained from patients aged from 55 to 75 with or without tinnitus. GRM7 analysis was performed by qPCR. Genotyping of single nucleotide polymorphisms (SNPs) in NAT2 was performed by PCR amplification followed by Sanger sequencing or by qPCR. Results: We screened samples from 78 individuals (33 men and 45 women). T allele at GRM7 gene was the most observed (60.3% T/T and 33.3% A/T). Individuals with a T/T genotype have a higher risk for ARHL and 33% lower risk for tinnitus, compared to individuals with A/A and A/T genotype, respectively. Being a slow acetylator (53%) was the most common NAT2 phenotype, more common in men (55.8%). Intermediate acetylator was the second most common phenotype (35.9%) also more frequent in men (82.6%). Noise exposed individuals and individuals with 'high frequency' hearing loss seem to have a higher risk for tinnitus. Our data suggests that allele AT of GRM7 can have a statistically significant influence toward the severity of tinnitus. Conclusion: For each increasing year of age the chance of HL increases by 9%. The risk for ARHL was not significantly associated with GRM7 neither NAT2. However, we cannot conclude from our data whether the presence of T allele at GRM7 increases the odds for ARHL or whether the A allele has a protective effect. Genotype A/T at GRM7 could potentially be considered a biomarker of tinnitus severity. This is the first study evaluating the effect of GRM7 and NAT2 gene in tinnitus.

Pertenece a

Repositório Comum  

Autor(es)

Haider, HF -  Flook, M -  Aparicio, M -  Ribeiro, D -  Antunes, M -  Szczepek, AJ -  Hoare, DJ -  Fialho, G -  Paço, JC -  Caria, H - 

Id.: 70963850

Idioma: eng  - 

Versión: 1.0

Estado: Final

Palabras claveIdoso - 

Tipo de recurso: article  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: openAccess

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 06-feb-2018

Contacto:

Localización:
* Front Aging Neurosci. 2017 Nov 1;9:346.
* 10.3389/fnagi.2017.00346

Otros recursos del mismo autor(es)

  1. Humanitarian logistics: the establishment of the nimbusdroid pluviometric monitoring system to rainfall spates, floods and overflows in the rochdale neighborhood Spates, floods and overflows are natural disasters and anthropogenic character responsible for stron...
  2. O tratamento destinado às diferenças nos currículos desenvolvimentista, psicomotor e crítico da Educação Física The treatment of differences in developmental, psychomotor and critical curricula for physical educa...
  3. Turismo, marketing e novos residentes: o caso de Almancil Dissertação de Mestrado, Gestão e Desenvolvimento em Turismo, Faculdade de Economia, Universidade do...
  4. Age-related hearing loss: is this a preventable condition? Trabalho apresentado em IEB 2015: Symposium & 52nd Inner Ear Biology Workshop, 12-15 setembro 2015, ...
  5. Chemical and spectroscopic characterization of humic acids extracted from the bottom sediments of a Brazilian subtropical microbasin International audience

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.